Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH
Brandt, J.T.; Triplett, D.A.; Alving, B.; Scharrer, I.
Thrombosis and Haemostasis 74(4): 1185-1190
1995
ISSN/ISBN: 0340-6245 PMID: 8560433 Document Number: 441204
Document emailed within 1 workday
Related Documents
Mosesson, M.W. 1995: Terminology for macromolecular derivatives of crosslinked fibrin. On behalf of the Subcommittee on Fibrinogen of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 73(4): 725-726Exner, T.; Triplett, D.A.; Taberner, D.; Machin, S.J. 1991: Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants Thrombosis and Haemostasis 65(3): 320-322
Foster, P.A. 1995: The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 74(2): 784-790
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Malaviya, A.N. 1991: Lupus anticoagulant, anticardiolipin antibody or antiphospholipid syndrome? Journal of the Association of Physicians of India 39(3): 239-241
Johns, A.S.; Chamley, L.; Ockelford, P.A.; Pattison, N.S.; McKay, E.J.; Corkill, M.; Hart, H. 1994: Comparison of tests for the lupus anticoagulant and antiphospholipid antibodies in systemic lupus erythematosus Clinical and Experimental Rheumatology 12(5): 523-526
Horbach, D.A.; van Oort, E.; Donders, R.C.; Derksen, R.H.; de Groot, P.G. 1996: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies Thrombosis and Haemostasis 76(6): 916-924
Wisløff, F.; Sletnes, K.; Godal, H.C. 1990: Antiphospholipid syndrome and lupus anticoagulant Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 110(1): 94
Pertusi, R.M. 1992: The lupus anticoagulant and antiphospholipid antibodies Journal of the American Osteopathic Association 92(8): 1021-1025
Tripodi, A.; Chantarangkul, V.; Clerici, M.; Mannucci, P.M. 2002: Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA Thrombosis and Haemostasis 88(4): 583-586
Karmochkine, M.; Cacoub, P.; Piette, J.C.; Godeau, P.; Boffa, M.C. 1992: Antiphosphatidylethanolamine antibody as the sole antiphospholipid antibody in systemic lupus erythematosus with thrombosis Clinical and Experimental Rheumatology 10(6): 603-605
van den Besselaar, A.M. 1990: Recommended method for reporting therapeutic control of oral anticoagulant therapy. Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Thrombosis and Haemostasis 63(2): 316-317
De Bandt, M.; Meyer, O.; Grossin, M.; Kahn, M.F. 1993: Lupus mastitis heralding systemic lupus erythematosus with antiphospholipid syndrome Journal of Rheumatology 20(7): 1217-1220
Fofi, C.; Cuadrado, M.J.; Godfrey, T.; Abbs, I.; Khamashta, M.A.; Hughes, G.R. 2001: Lack of association between antiphospholipid antibody and WHO classification in lupus nephritis Clinical and Experimental Rheumatology 19(1): 75-77
Ichikawa, Y.; Tsunematsu, T.; Yokohari, R.; Tanimoto, K.; Sakane, T.; Yoshida, H.; Kano, S.; Sawada, S.; Hashimoto, H.; Nagasawa, T. 1985: Multicenter study of causes of death in systemic lupus erythematosus-a report from the Subcommittee for Development of Therapy, the Research Committee for Autoimmune Diseases Supported by the Ministry of Health and Welfare Ryumachi 25(4): 258-264
Asherson, R.A.; Lanham, J.G.; Hull, R.G.; Boey, M.L.; Gharavi, A.E.; Hughes, G.R. 1984: Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant" Clinical and Experimental Rheumatology 2(1): 75-79
Raleigh-Rosendo, R.; Diez-Ewald, M.; Vizcaíno, G.; Fereira, H.; Arteaga-Vizcaíno, M.; Arreaza, M. 1990: Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities Investigacion Clinica 31(1): 45-55
Wysocka, K.; Kiczak, J.; Pozorska, D. 1977: Immunocoagulopathy (lupus anticoagulant) with severe hemorrhagic diathesis in systemic lupus erythematosus Wiadomosci Lekarskie 30(14): 1129-1134
Engelsen, J.; Nielsen, S.M.; Thorsen, S. 2006: Serious bleeding in systemic lupus erythematosus complicated by lupus anticoagulant-hypoprothrombinaemia syndrome Ugeskrift for Laeger 168(5): 486-487
Destée, A.; Devos, P.; Prin, L.; Warot, M.; Warot, P. 1985: Brain stem infarction, systemic lupus erythematosus and circulating lupus anticoagulant Revue Neurologique (Paris) 141(3): 236-239